NCT04381962 A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) Status COMPLETED Phase PHASE3
NCT04379713 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants Status COMPLETED Phase PHASE3
NCT04375150 Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC Status COMPLETED Phase N/A
NCT04370054 Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals Status COMPLETED Phase PHASE2/PHASE3
NCT04362852 Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic Dermatitis Status COMPLETED Phase N/A
NCT04362072 Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer Status COMPLETED Phase PHASE4
NCT04360941 PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer Status RECRUITING Phase PHASE1
NCT04360187 Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT04355845 A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS. Status COMPLETED Phase PHASE1
NCT04355156 Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT04353466 Assessing the Impact of Elelyso on Bone Involvement Currently Treated With Other ERTs Status COMPLETED Phase NA
NCT04351334 Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns Status COMPLETED Phase N/A
NCT04350606 A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia Status COMPLETED Phase PHASE3
NCT04347161 Implementation Strategies for Monitoring Adherence in Real Time Status ACTIVE_NOT_RECRUITING Phase NA
NCT04346615 Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen Status TERMINATED Phase PHASE2/PHASE3
NCT04345367 Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy Status COMPLETED Phase PHASE3
NCT04341181 ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling Status RECRUITING Phase PHASE2